Ochsner Connected Health, part of New Orleans-based Ochsner Health, has partnered with Crux to expand access to affordable obesity care through a new employer benefits platform.
Under the agreement, Ochsner will serve as the first cardiometabolic care provider on Crux’s platform, combining remote clinical services with cost-effective access to GLP-1 medications, according to a Jan. 7 Ochsner Health news release. Ochsner will deliver care through its Digital Medicine program, which offers evidence-based treatment for obesity, hypertension and Type 2 diabetes.
Crux, which contracts directly with drug manufacturers, will provide GLP-1 medications using a pass-through pricing model that avoids pharmacy benefit manager involvement and complex reimbursement processes. The combined approach aims to reduce costs while supporting long-term weight management and cardiometabolic health.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
